Startseite>>Analytical Standards>>25T-NBOMe (hydrochloride)

25T-NBOMe (hydrochloride) (Synonyms: 2C-T-NBOMe)

Katalog-Nr.GC42111

2C-T is a 2,5-dimethoxy phenethylamine that has structural and pharmacokinetic properties similar to the psychedelic mescaline.

Products are for research use only. Not for human use. We do not sell to patients.

25T-NBOMe (hydrochloride) Chemische Struktur

Cas No.: 1539266-47-1

Größe Preis Lagerbestand Menge
1mg
43,00 $
Auf Lager
5mg
117,00 $
Auf Lager
10mg
163,00 $
Auf Lager
50mg
472,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

2C-T is a 2,5-dimethoxy phenethylamine that has structural and pharmacokinetic properties similar to the psychedelic mescaline. [1]  25T-NBOMe is a derivative of 2C-T having an N-(2-methoxybenzyl) addition at the amine. This addition on related phenethylamines increases the affinity and selectivity for the 5-HT2A receptor over other serotonin receptors. [2] This product is intended for forensic and research purposes.

Reference:
[1]. Nichols, D.E., and Shulgin, A.T. Sulfur analogs of psychotomimetic amines. Journal of Pharmaceutical Sciences 65(10), 1554-1556 (1976).
[2]. Braden, M.R., Parrish, J.C., Naylor, J.C., et al. Molecular interaction of serotonin 5-HT2A receptor residues Phe3396.51 and Phe3406.52 with superpotent N-benzyl phenethylamine agonists. Mol. Pharm. 70(6), 1956-1965 (2006).

Bewertungen

Review for 25T-NBOMe (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 25T-NBOMe (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.